Exicure (XCUR) Expected to Announce Earnings on Wednesday

Exicure (NASDAQ:XCUR) will likely be issuing its resultson Wednesday, May 13th. Analysts expect the company to announce earnings of ($18.60) per share and revenue of $1.6440 million for the quarter.

Exicure (NASDAQ:XCUR) last released its earnings results on Wednesday, March 25th. The company reported ($0.46) EPS for the quarter, beating the consensus estimate of ($18.60) by $18.14.

Exicure Stock Up 4.6%

Shares of XCUR stock opened at $3.40 on Wednesday. The firm has a market cap of $21.67 million, a price-to-earnings ratio of -4.42 and a beta of 3.62. Exicure has a 12 month low of $3.10 and a 12 month high of $11.86. The stock has a 50-day moving average price of $3.97 and a 200 day moving average price of $4.60.

Analysts Set New Price Targets

Separately, Wall Street Zen raised shares of Exicure to a “hold” rating in a research note on Saturday, January 17th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has an average rating of “Sell”.

About Exicure

Exicure is a clinical‐stage biotechnology company pioneering the development of next‐generation genetic medicines through its proprietary spherical nucleic acid (SNA) delivery platform. This nanotechnology‐based approach is designed to facilitate the intracellular delivery of oligonucleotide therapeutics, addressing longstanding challenges in targeting hard‐to‐reach tissues such as the central nervous system.

The company’s pipeline encompasses programs for neurological disorders—including Huntington’s disease, Parkinson’s disease and Alzheimer’s disease—as well as exploratory efforts in dermatological indications and oncology.